Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Methyl caprate greatly increases drug absorption through the skin and is better than other enhancers.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Invasomes loaded with clotrimazole gel could improve drug delivery through the skin for fungal treatment.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

A new method creates unique chemical structures that could improve drug discovery.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Natural products can help overcome cancer drug resistance.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Platelet-rich plasma can temporarily inhibit some drug-resistant bacteria in diabetic foot infections.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The model and estimator can predict drug exposure in kidney transplant patients well.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Optimized emulgels with Levofloxacin effectively treat eye infections with prolonged drug release and safety.